Publication | Open Access

Brentuximab Vedotin Demonstrates Activity in a Patient With Plasmablastic Lymphoma Arising From a Background of Chronic Lymphocytic Leukemia

Hematological MalignancyTumor BiologyLymphoid NeoplasiaChronic Lymphocytic LeukemiaMedicinePlasmablastic Lymphoma ArisingImmunologyHematologyPathologyLymphatic DiseaseAdult T-cell Leukemia-lymphomaOncologyCancer ResearchBrentuximab Vedotin